PepGen Inc. Share Price

PepGen Inc. Share Price

NASDAQ: PEPG | Micro Cap
$2.42
-$0.13 (-4.92%) Last updated on 30 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

PepGen Inc. Stock Performance

Open
$2.62
Prev. Close
$2.54
Circuit Range
N/A
Day Range
$2.40 - $2.62
Year Range
$1.31 - $7.79
Volume
83,171
Average Traded
$2.48

PepGen Inc. Share Price Today

As of 30 October 2026, PepGen Inc.'s share price is $2.42. The stock opened at $2.62, compared to its previous close of $2.54. During today's trading session, PepGen Inc.'s share price traded between $2.40 and $2.62, with an average price of $2.51. Over the past 52 weeks, the stock has recorded a high of $7.79 and a low of $1.31. In terms of performance, PepGen Inc.'s share price has risen by 46.81% over the last six months and is down 48.18% on a year-on-year basis.

PepGen Inc. Share Price Chart

Line chart of the PepGen Inc. price trend over the selected period. The price fell overall, ranging from 2.40 to 2.62, ending at 2.42.
$2.40$2.62
L
Show Current Price
H

PepGen Inc. Stock Fundamentals & Key Indicators

Market Cap
$101.97M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.04
Revenue (TTM)
$0.00
Return On Equity (TTM)
-60.19%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
1.22%

PepGen Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$18.03-$18.34-$17.76-$17.81
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-1.72%3.16%-0.28%

PepGen Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$69.10-$78.63-$89.98-$89.66
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-13.79%-14.43%0.36%

About PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.

PepGen Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$2.38
$2.40
-0.41%
Sep 2026
$2.98
$2.42
-21.59%
Aug 2026
$1.78
$3.08
+74.01%
Jul 2026
$1.80
$1.77
-1.39%
Jun 2026
$1.47
$1.79
+18.87%
May 2026
$1.65
$1.51
-8.21%
Apr 2026
$1.76
$1.65
-5.73%
Mar 2026
$6.02
$1.75
-71.90%
Feb 2026
$5.15
$6.21
+21.29%
Jan 2026
$6.40
$5.12
-21.59%
Dec 2025
$6.24
$6.53
+1.71%
Nov 2025
$4.70
$6.42
+37.77%

PEPG Share Price FAQs